Fat Grafting for the Treatment of Scleroderma

Plast Reconstr Surg. 2019 Dec;144(6):1498-1507. doi: 10.1097/PRS.0000000000006291.

Abstract

Background: Scleroderma is a chronic connective tissue disease that results in fibrosis of the skin and internal organs. Although internal organ involvement corresponds with poor prognosis, systemic agents are effective at improving the effects of scleroderma on internal organs. In contrast, skin manifestations are universally present in all patients diagnosed with scleroderma, yet no systemic agents have been shown to be successful. Fat grafting has been shown to improve skin quality and improve contour irregularities and may be helpful in the treatment of patients with scleroderma.

Methods: The authors performed a thorough review of the pathophysiology of scleroderma and the current treatment options for scleroderma. The efficacy of fat grafting for the treatment of scleroderma and the mechanism by which fat grafting improves outcomes was also discussed.

Results: Scleroderma is characterized by chronic inflammation and vascular compromise that leads to fibrosis of the skin and internal organs. Fat grafting has recently been the focus of significant basic science research. It has been shown to reduce inflammation, reduce fibrosis by limiting extracellular matrix proteins and increasing collagenase activity, and provide structural support through stem cell proliferation and differentiation. The adipocytes, adipose stem cells, endothelial cells, and vascular smooth muscle cells in the processed fat likely contribute to the effectiveness of this treatment.

Conclusions: Fat grafting in scleroderma patients likely improves skin manifestations by recreating fullness, correcting contour deformities, and improving skin quality. The injected fat provides a mixture of cells that influences the recipient site, resulting in improved outcomes.

Publication types

  • Review

MeSH terms

  • Adipose Tissue / immunology
  • Adipose Tissue / transplantation*
  • Adult
  • Cell Differentiation / physiology
  • Cell Proliferation / physiology
  • Collagenases / metabolism
  • Extracellular Matrix Proteins / metabolism
  • Facial Dermatoses / therapy
  • Female
  • Fibrosis / prevention & control
  • Hand Dermatoses / therapy
  • Humans
  • Joint Diseases / immunology
  • Joint Diseases / therapy
  • Middle Aged
  • Neovascularization, Physiologic / physiology
  • Scleroderma, Localized / immunology
  • Scleroderma, Localized / therapy*
  • Scleroderma, Systemic / immunology
  • Scleroderma, Systemic / therapy*
  • Stem Cells / physiology
  • Transplantation Immunology / physiology
  • Transplantation, Autologous

Substances

  • Extracellular Matrix Proteins
  • Collagenases